Content about Pharmaceutical drug

May 17, 2012
FDA approves generic versions of Plavix

The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.

May 16, 2012
Generic Plavix arrives at Walmart, Sam's Club stores

Walmart and Sam's Club will be among the first retailers to offer a generic version of an antiplatelet drug.

May 2, 2012
MinuteClinic to support Million Hearts with free blood-pressure checks in May

CVS Caremark announced on Wednesday that it is supporting Million Hearts during National High Blood Pressure Education Month in May through a number of patient-focused initiatives.

April 19, 2012
'Doughnut hole' gap's impact on adherence spells opportunity for community pharmacy

The study's findings that the Part D coverage gap — or “doughnut hole” — led to a significant gap in the adherence of cardiovascular medications may not come as a complete surprise; however, it undoubtedly underscores the important role that pharmacy can play in helping patients navigate plan strategies that promote the use of lower-cost medications.

April 17, 2012
More than $2 billion added to workers' compensation pharmacy costs, report finds

Workers' compensation pharmacy costs took on an extra $2.1 billion in 2011 due to unnecessary use of more expensive drugs, according to a new report by pharmacy benefit manager Express Scripts.

April 17, 2012
Study unveils drop in adherence to cardiovascular meds during 'doughnut hole' gap

Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.

April 13, 2012
Drug makers invested $49.5 billion in R&D in 2011, report finds

Drug companies invested nearly $50 billion in research and development in 2011, according to a new report by a drug industry trade group.

April 10, 2012
Rite Aid offers Prescription Advisor reports

Rite Aid is offering personalized reports designed to increase medication adherence, the company said Tuesday.

March 29, 2012
Kline unveils 2011 drivers of U.S. OTC market

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

March 26, 2012
Suppliers, FDA shine spotlight on switches

The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


March 19, 2012
NCPA applauds local pharmacist for participation in Dispose My Meds

The National Community Pharmacists Association has applauded a member of its organization for participating in the organization's drug disposal program.

March 9, 2012
FidoPharm launches Pet Trust Plus

A company that makes pet drugs has launched what it calls the first generic prescription heartworm preventive medication for sale at retail pharmacies around the country.

March 9, 2012
Kerr Drug, UNC pharmacy school to collaborate in pharmacogenetic study

A regional retail pharmacy chain and a nearby school of pharmacy will collaborate on a study to evaluate the implementation of a pharmacogenetic program in a community pharmacy setting.

March 8, 2012
FDA mulls over making some prescription drugs available over the counter

The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

March 8, 2012
NACDS expresses pharmacy's commitment to patient safety in House Panel testimony

Written testimony submitted by the National Association of Chain Drug Stores underscored chain pharmacies’ commitment to patient safety as part of the next Prescription Drug User Fee Act reauthorization, and emphasized that community pharmacist-provided services help improve health outcomes without the introduction of unproven technologies.

March 5, 2012
Study finds Teva allergy drug safe, effective

A drug under development by Teva Pharmaceutical Industries appears safe and effective in treating allergies, according to results of a late-stage clinical trial released Monday.

February 17, 2012
ReportersNotebook — Chain Pharmacy, 2/27/12

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said. Merck announced the approval of Janumet XR (sitagliptin and metformin hydrochloride) extended-release tablets as a once-daily treatment for the disease.


February 17, 2012
Switching things up

Clarinex (desloratadine), the next-generation prescription allergy remedy to the second-generation Claritin, is 1-of-3 blockbuster prescription medicines that may make the crossover from prescription-only to over-the-counter in the near future.

February 8, 2012
BI study: No drug interaction between Aggrenox, omeprazole

An antiplatelet medication created by Boehringer Ingelheim is not affected when co-administered with a proton-pump inhibitor, according to results of a drug interaction study.

February 1, 2012
Impax licenses migraine drug rights from AstraZeneca

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

January 26, 2012
Federal court clears way for Watson, Amphastar to launch generic version of Lovenox

A federal court has stopped an injunction that would have prevented drug maker Watson Pharmaceuticals and partner company Amphastar Pharmaceuticals from marketing or selling a generic version of a blood-thinning drug.

January 24, 2012
Oxecta now commercially available

A pain medication that utilizes Acura Pharmaceuticals' Aversion technology now is commercially available.

January 20, 2012
Generics face new and long-standing issues

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

January 20, 2012
Lipitor’s patent loss signals future for other top drugs

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot.

January 18, 2012
Frost & Sullivan forecasts strong growth in generic drug market through 2017

Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

© 2012 Drug Store News. All Rights Reserved.